(Q41830683)

12 October 2017

An orally active formulation of angiotensin-(1-7) produces an antithrombotic effect (English)

1 reference

12 October 2017

5

1 reference

12 October 2017

Frederico B De Sousa

3

0 references

Natalia Alenina

4

object named as

Natalia Alenina

1 reference

12 October 2017

Rodrigo Araujo Fraga-Silva

1

1 reference

12 October 2017

Fabiana P Costa-Fraga

2

1 reference

12 October 2017

Ruben D Sinisterra

6

1 reference

12 October 2017

Robson A S Santos

7

1 reference

12 October 2017

1 January 2011

1 reference

12 October 2017

1 reference

12 October 2017

66

1 reference

12 October 2017

5

1 reference

12 October 2017

837-841

1 reference

Angiotensin-(1-7) as an antihypertensive, antifibrotic target.

12 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109384

Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109384

The antithrombotic effect of angiotensin-(1-7) involves mas-mediated NO release from platelets

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109384

Study of angiotensin-(1-7) vasoactive peptide and its beta-cyclodextrin inclusion complexes: complete sequence-specific NMR assignments and structural studies

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109384

Angiotensin-(1-7): pharmacology and new perspectives in cardiovascular treatments

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109384

Angiotensin-(1-7) and its receptor as a potential targets for new cardiovascular drugs

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109384

Chronic infusion of angiotensin-(1-7) reduces heart angiotensin II levels in rats.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109384

Design and evaluation of cyclodextrin-based drug formulation

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109384

Platelets and cardiovascular disease

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109384

Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109384

Angiotensin-(1-7): an active member of the renin-angiotensin system.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109384

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109384

Nitric oxide insufficiency, platelet activation, and arterial thrombosis

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109384

Angiotensin-(1-7): an update.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109384

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109384

Counterregulatory actions of angiotensin-(1-7).

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109384

Short-term angiotensin(1-7) receptor MAS stimulation improves endothelial function in normotensive rats

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109384

Antithrombotic effect of captopril and losartan is mediated by angiotensin-(1-7).

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109384

Angiotensin-(1-7): cardioprotective effect in myocardial ischemia/reperfusion

18 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3109384

Angiotensin-(1–7) Attenuates the Development of Heart Failure After Myocardial Infarction in Rats

18 August 2018

1 reference

12 December 2020

Hypertension, platelets, and the endothelium: the "thrombotic paradox" of hypertension (or "Birmingham paradox") revisited

1 reference

12 December 2020

Plasma angiotensin(1-7) immunoreactivity is increased by salt load, water deprivation, and hemorrhage

1 reference

12 December 2020

Angiotensin-(1-7) dilates canine coronary arteries through kinins and nitric oxide

1 reference

12 December 2020

Effect of angiotensin-(1-7) on reperfusion arrhythmias in isolated rat hearts

1 reference

12 December 2020

Angiotensin-(1-7) contributes to the antihypertensive effects of blockade of the renin-angiotensin system

1 reference

12 December 2020

10.1590/S1807-59322011000500021

Identifiers

DOI

1 reference

12 October 2017

0 references

1 reference

12 October 2017

PubMed publication ID

21789389

1 reference